NASDAQ:AMEH

Apollo Medical Stock Forecast, Price & News

$48.34
+8.13 (+20.22 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$45.23
$48.48
50-Day Range
$26.44
$48.34
52-Week Range
$15.11
$48.48
Volume1.84 million shs
Average Volume184,469 shs
Market Capitalization$2.66 billion
P/E Ratio39.95
Dividend YieldN/A
Beta0.49
30 days | 90 days | 365 days | Advanced Chart
Receive AMEH News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.


Apollo Medical logo

About Apollo Medical

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.44 out of 5 stars

Medical Sector

1481st out of 2,099 stocks

Management Consulting Services Industry

25th out of 50 stocks

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Apollo Medical (NASDAQ:AMEH) Frequently Asked Questions

What stocks does MarketBeat like better than Apollo Medical?

Wall Street analysts have given Apollo Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Apollo Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Apollo Medical?

Apollo Medical saw a increase in short interest in the month of May. As of May 14th, there was short interest totaling 488,000 shares, an increase of 26.0% from the April 29th total of 387,300 shares. Based on an average daily volume of 91,800 shares, the short-interest ratio is currently 5.3 days.
View Apollo Medical's Short Interest
.

When is Apollo Medical's next earnings date?

Apollo Medical is scheduled to release its next quarterly earnings announcement on Friday, August 6th 2021.
View our earnings forecast for Apollo Medical
.

How were Apollo Medical's earnings last quarter?

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) announced its quarterly earnings data on Tuesday, May, 4th. The company reported $0.30 EPS for the quarter, topping analysts' consensus estimates of $0.22 by $0.08. The business had revenue of $176.06 million for the quarter. Apollo Medical had a net margin of 6.73% and a trailing twelve-month return on equity of 16.81%.
View Apollo Medical's earnings history
.

How has Apollo Medical's stock price been impacted by Coronavirus (COVID-19)?

Apollo Medical's stock was trading at $14.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AMEH stock has increased by 243.6% and is now trading at $48.34.
View which stocks have been most impacted by COVID-19
.

What guidance has Apollo Medical issued on next quarter's earnings?

Apollo Medical issued an update on its second quarter 2021 earnings guidance on Tuesday, June, 8th. The company provided earnings per share guidance of $- for the period. The company issued revenue guidance of $163 million-173 million, compared to the consensus revenue estimate of $170.90 million.

Who are Apollo Medical's key executives?

Apollo Medical's management team includes the following people:
  • Dr. Kenneth T. Sim M.D., Exec. Chairman & Co-Chief Exec. Officer (Age 67, Pay $1.07M)
  • Dr. Thomas S. Lam M.P.H., M.D., Pres, Co-CEO & Director (Age 72, Pay $1.07M)
  • Mr. Eric Chin, CFO & Corp. Sec. (Age 41, Pay $351.21k)
  • Dr. WaiChow Young M.D., Chief Admin. Officer (Age 74, Pay $346.79k)
  • Dr. Adrian Vazquez, Chief Medical Officer (Age 51, Pay $517.06k)
  • Mr. Brandon Sim, CTO & COO (Age 27)
  • Dr. Jeremy R. Jackson M.D., Chief of Staff

What is Thomas Lam's approval rating as Apollo Medical's CEO?

9 employees have rated Apollo Medical CEO Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among Apollo Medical's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Apollo Medical's key competitors?

What other stocks do shareholders of Apollo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), The Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Square (SQ) and Exxon Mobil (XOM).

What is Apollo Medical's stock symbol?

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

Who are Apollo Medical's major shareholders?

Apollo Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (2.71%), Ophir Asset Management Pty Ltd (0.76%), Geode Capital Management LLC (0.62%), Northern Trust Corp (0.45%), JPMorgan Chase & Co. (0.30%) and GW&K Investment Management LLC (0.26%). Company insiders that own Apollo Medical stock include Adrian Vazquez, Albert Waichow Young, Brandon Sim, Eric Chin, John Chiang, Kenneth T Sim, Michael F Eng, Physicians Of Californi Allied and Thomas S Lam.
View institutional ownership trends for Apollo Medical
.

Which major investors are selling Apollo Medical stock?

AMEH stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Northern Trust Corp, Credit Suisse AG, Goldman Sachs Group Inc., Renaissance Technologies LLC, UBS Group AG, Alliancebernstein L.P., and Citigroup Inc.. Company insiders that have sold Apollo Medical company stock in the last year include Adrian Vazquez, and Physicians Of Californi Allied.
View insider buying and selling activity for Apollo Medical
or view top insider-selling stocks.

Which major investors are buying Apollo Medical stock?

AMEH stock was bought by a variety of institutional investors in the last quarter, including Ophir Asset Management Pty Ltd, GW&K Investment Management LLC, Royal Bank of Canada, Victory Capital Management Inc., Citadel Advisors LLC, Cornercap Investment Counsel Inc., D.A. Davidson & CO., and Geode Capital Management LLC. Company insiders that have bought Apollo Medical stock in the last two years include Albert Waichow Young, Brandon Sim, Eric Chin, John Chiang, Kenneth T Sim, Michael F Eng, Physicians Of Californi Allied, and Thomas S Lam.
View insider buying and selling activity for Apollo Medical
or or view top insider-buying stocks.

How do I buy shares of Apollo Medical?

Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apollo Medical's stock price today?

One share of AMEH stock can currently be purchased for approximately $48.34.

How much money does Apollo Medical make?

Apollo Medical has a market capitalization of $2.66 billion and generates $687.18 million in revenue each year. The company earns $37.87 million in net income (profit) each year or $1.01 on an earnings per share basis.

How many employees does Apollo Medical have?

Apollo Medical employs 630 workers across the globe.

What is Apollo Medical's official website?

The official website for Apollo Medical is www.apollomed.net.

Where are Apollo Medical's headquarters?

Apollo Medical is headquartered at 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801.

How can I contact Apollo Medical?

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The company can be reached via phone at 626-282-0288 or via email at [email protected]


This page was last updated on 6/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.